Provider Reviews

TrimRx vs Wellmedr: Pricing, shipping, and compounded GLP-1 plans

TrimRx vs Wellmedr: both sell GLP-1 weight-loss plans online, but they differ on price points, shipping speed, medication type, and guarantees. Early verdict: TrimRx emphasizes a $149 starting plan, Lifetime Price Protection, and 1-2 day shipping, while Wellmedr promotes lower starting prices from $89/month, same-day review and a money-back promise.

Compare TrimRx plans starting at $149

How TrimRx and Wellmedr compare at a glance

This comparison focuses on the most distinctive supported differences: starting price and promotions, shipping and review speed, compounded versus branded prescriptions and regulatory notes, and guarantees or price protection clauses. Each point below compares TrimRx and Wellmedr directly using only the supplied facts.

1. Starting price and promotional offers

TrimRx lists weight-loss plans starting at $149/month and cites a $140 promotional discount. TrimRx highlights GLP-1 injections from $149/month and GLP-1+GIP from $249/month. Wellmedr advertises semaglutide from $89/month and mentions promotional sale claims like $49/mo on 12 month plans or locking in $200 off every month for life. Both provide specific starting price claims in their materials.

See Wellmedr plans starting at $89

2. Shipping speed and review timing

TrimRx promotes free shipping that arrives in 1-2 days and states prescription and telemed visits are included. Wellmedr highlights same-day review and free overnight shipping or guaranteed on-time refills. If rapid shipping is a priority, both claim fast fulfillment but TrimRx calls out 1-2 day delivery while Wellmedr emphasizes overnight shipping and on-time refill guarantees.

3. Medication type, compounding, and regulatory notes

Both providers offer compounded GLP-1 options and include the same regulatory qualifier: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. TrimRx specifically frames its program as a compounded medication program prepared and shipped by a state-licensed sterile compounding pharmacy and notes that they do not sell, dispense, or ship branded medications; if a branded medication is prescribed the patient fills it separately. Wellmedr likewise offers compounded GLP-1 exclusively from licensed U.S. pharmacies and includes a required safety notice about potential risks and the lack of FDA evaluation.

4. Price protection, guarantees, and risk statements

TrimRx offers Lifetime Price Protection: lock in today’s price for life and pay the same price on every dose, with no dose-based increases, plus claims no monthly membership and cancel anytime. Wellmedr also advertises lifetime locked-in pricing and no dose-based price increases, and additionally promotes a money back guarantee claiming a 100% refund if you do not lose weight in 90 days. Both providers qualify medications as compounded and not FDA-reviewed; Wellmedr includes explicit safety warnings about thyroid C-cell tumors and MTC risks in its materials.

Comparison table: TrimRx vs Wellmedr

Criteria TrimRx Wellmedr
Starting price GLP-1 from $149/month; GLP-1+GIP from $249/month Semaglutide from $89/month; semaglutide plans as low as $49/mo on some 12 month offers
Promotions $140 promotional discount cited Labor Day style sale claims: lock in $200 off or $49/mo on 12 month plans; new customer offer $150 off for life
Shipping speed Free 1-2 day shipping Same-day review plus free overnight shipping and on-time refill guarantees
Medication model Compounded medications prepared by licensed compounding pharmacies; branded prescriptions filled separately Compounded GLP-1 exclusively from licensed U.S. pharmacies
Price protection Lifetime Price Protection: lock in today’s price for life Lifetime locked-in pricing and no dose-based price increases
Guarantees No weight-loss guarantee; program guidance and average outcomes claimed in marketing Claims a money back guarantee if no weight loss in 90 days
Regulatory note Compounded medications are not FDA-approved and are not reviewed by FDA Compounded medications are not FDA-approved and are not reviewed by FDA; includes specific safety warnings

5. Outcomes, support, and scale

TrimRx cites service to 100,000+ customers and a 4.8 Excellent Rating and describes 24/7 support and care guidance. Wellmedr materials reference published clinical research on GLP-1 medications but do not include the same customer count or rating in the captured evidence. Both note that individual results vary and that treatment requires medical evaluation and clinician approval.

Review TrimRx pricing and features

Bottom line and final guidance for TrimRx vs Wellmedr

TrimRx vs Wellmedr choice depends on what matters most: TrimRx centers on a $149 starting compounded GLP-1 option, Lifetime Price Protection, 1-2 day shipping and a large stated customer base. Wellmedr highlights lower starting prices from $89 or promotional $49/mo plans, same-day review, overnight shipping and an advertised money-back guarantee. Both disclose that compounded medications are not FDA-approved and require clinician review.

Explore Wellmedr pricing and review terms

Choose TrimRx if…

you prefer a program that advertises compounded GLP-1 from $149/month, Lifetime Price Protection that locks in price for life, free 1-2 day shipping, included telehealth visits, and the provider scale noted in their materials.

Choose Wellmedr if…

you prioritize lower advertised entry pricing such as semaglutide plans starting at $89/month or promotional $49/mo offers, same-day clinical review, overnight shipping and an advertised money-back guarantee for 90 days.

Ready to Compare Telehealth Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Related articles

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.